Karacaglar Emir, Bal Ugur, Ciftci Orcun, Turgay Ozge, Yilmaz Mustafa, Sade Elif, Aydinalp Alp, Sezgin Atilla, Atar Ilyas, Muderrisoglu Haldun
From the Department of Cardiology, Başkent University, Ankara, Turkey.
Exp Clin Transplant. 2015 Nov;13 Suppl 3:146-8. doi: 10.6002/ect.tdtd2015.P78.
Hematologic parameters, such as mean platelet volume, red-cell distribution width, and neutrophil-to-lymphocyte ratio, have prognostic value in multiple cardiac conditions such as stable angina pectoris, acute coronary syndromes, and heart failure. However, no previous studies have evaluated the association between hematologic parameters and asymptomatic graft rejection after heart transplant. We evaluated the role of hematologic parameters for detecting asymptomatic graft rejection after heart transplant.
We retrospectively evaluated medical records of 47 adult patients who underwent orthotopic heart transplant between February 25, 2005, and July 6, 2014, in our hospital, noting their hematologic parameters before each biopsy. Two groups were created according to biopsy results: rejection and no-rejection.
We excluded 4 patients who died during the first month posttransplant owing to early complications. We evaluated 422 endomyocardial biopsy results of 43 adult patients (mean age, 43.4 ± 11.4 y; 14 women). Mean follow-up was 33 months. A total of 109 biopsies performed because of clinical suspicion of rejection were excluded. Red-cell distribution width levels were similar between groups (17.2% ± 2.6% in the rejection group and 17.1% ± 2.5% in the no-rejection group; P = .856). Neutrophil-to-lymphocyte ratio was similar between groups (7.8 ± 9.9 in the rejection group and 8.2 ± 9.7 in the no-rejection group; P = .791). Mean platelet volume levels were significantly lower in the rejection group (8.3 ± 1.3 fL) than in the no-rejection group (8.8 ± 1.8 fL) (P = .037) (Table 1).
According to our results, only lower mean platelet volume levels were significantly associated with asymptomatic graft rejection in patients with a transplanted heart. More detailed analyses are needed to exclude the effects of immunosuppressant drugs, and further studies are needed to clarify the exact role of hematologic parameters for detecting asymptomatic rejection after heart transplant.
血液学参数,如平均血小板体积、红细胞分布宽度和中性粒细胞与淋巴细胞比值,在多种心脏疾病(如稳定型心绞痛、急性冠状动脉综合征和心力衰竭)中具有预后价值。然而,既往尚无研究评估血液学参数与心脏移植后无症状移植物排斥反应之间的关联。我们评估了血液学参数在检测心脏移植后无症状移植物排斥反应中的作用。
我们回顾性评估了2005年2月25日至2014年7月6日在我院接受原位心脏移植的47例成年患者的病历,记录每次活检前的血液学参数。根据活检结果分为两组:排斥组和非排斥组。
我们排除了4例移植后第一个月因早期并发症死亡的患者。我们评估了43例成年患者(平均年龄43.4±11.4岁;14例女性)的422次心内膜活检结果。平均随访时间为33个月。因临床怀疑排斥反应而进行的109次活检被排除。两组间红细胞分布宽度水平相似(排斥组为17.2%±2.6%,非排斥组为17.1%±2.5%;P = 0.856)。两组间中性粒细胞与淋巴细胞比值相似(排斥组为7.8±9.9,非排斥组为8.2±9.7;P = 0.791)。排斥组的平均血小板体积水平(8.3±1.3 fL)显著低于非排斥组(8.8±1.8 fL)(P = 0.037)(表1)。
根据我们的结果,在心脏移植患者中,只有较低的平均血小板体积水平与无症状移植物排斥反应显著相关。需要更详细的分析以排除免疫抑制药物的影响,还需要进一步研究以阐明血液学参数在检测心脏移植后无症状排斥反应中的确切作用。